BIOMAT Database Logo BIOMAT Database Logo

Long-term results of conversion from existing to microemulsion formulation of cyclosporine. 1996

H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Department of Medicine-Nephrology, Humboldt University of Berlin, Germany.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004304 Dosage Forms Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. Dosage Form,Form, Dosage,Forms, Dosage
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation.
August 1998, Transplantation proceedings,
H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation.
December 1996, Transplantation proceedings,
H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.
August 1998, Transplantation proceedings,
H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Conversion of patients to cyclosporine E microemulsion.
May 1998, Transplantation proceedings,
H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results.
October 1994, Transplantation proceedings,
H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Cyclosporine conversion from conventional to microemulsion formulation: effect on renal concentration ability in stable hepatic transplant recipients.
January 1997, Transplantation proceedings,
H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
August 1998, Transplantation proceedings,
H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
August 1998, Transplantation proceedings,
H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Elective conversion from cyclosporine to azathioprine: long-term follow-up.
February 1987, Transplantation proceedings,
H H Neumayer, and L Färber, and K Budde, and R Kohnen, and A Maibücher, and A Schuster, and J Vollmar, and J Waiser, and F C Luft
Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.
August 1998, Transplantation proceedings,
Copied contents to your clipboard!